title: Pyelonephritis caused by mesalazine.
authors.forename: G E
authors.initials: GE
authors.lastname: Russo
authors.forename: B
authors.initials: B
authors.lastname: Bauco
authors.forename: M
authors.initials: M
authors.lastname: Bosco
authors.forename: M
authors.initials: M
authors.lastname: Bonello
authors.forename: M F
authors.initials: MF
authors.lastname: Bisciglia
authors.forename: A
authors.initials: A
authors.lastname: De Paola
authors.forename: S
authors.initials: S
authors.lastname: Villatico Campbell
authors.forename: D
authors.initials: D
authors.lastname: Fava
authors.forename: E
authors.initials: E
authors.lastname: Vitaliano
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001772:Blood Cell Count; D001799:Blood Sedimentation; D006417:Hematuria; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D019804:Mesalamine / Q000009:adverse effects*; D011507:Proteinuria; D011704:Pyelonephritis / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine